Commentary on "Localized pigmentation disorder after subcutaneous pegylated interferon beta 1a injection" by Coghe et al.

被引：0
|
作者：
Porter, Bernadette [1 ]
机构：
[1] UCLH, Natl Hosp Neurol & Neurosurg, Queen Sq, London WC1N 3BG, England
来源：
MULTIPLE SCLEROSIS JOURNAL | 2018年 / 24卷 / 02期
关键词：
REMITTING MULTIPLE-SCLEROSIS; SKIN REACTIONS; ADHERENCE; VITILIGO; MS;
D O I：
10.1177/1352458517719153
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：233 / 235
页数：3
相关论文
共 14 条
  • [1] Localized pigmentation disorder after subcutaneous pegylated interferon beta-1a injection
    Coghe, Giancarlo
    Atzori, Laura
    Frau, Jessica
    Fenu, Giuseppe
    Lorefice, Lorena
    Marrosu, Maria Giovanna
    Cocco, Eleonora
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (02) : 231 - 233
  • [2] Reduction of injection-site reactions with hydrocortisone, witch hazel, or moisturising lotion after subcutaneous interferon beta 1a treatment for multiple sclerosis
    Ross, A. Perrin
    Singer, B.
    Kresa-Reahl, K.
    Mikol, D.
    AL-Sabbagh, A.
    Bennett, R.
    Divan, V.
    MULTIPLE SCLEROSIS, 2007, 13 : S134 - S135
  • [3] Pharmacokinetics and Pharmacodynamics of Interferon Beta-la (IFNβ-1a) in Healthy Volunteers after Intravenous, Subcutaneous or Intramuscular Administration
    John Alam
    Arthur McAllister
    James Scaramucci
    Wendy Jones
    Mark Rogge
    Clinical Drug Investigation, 1997, 14 : 35 - 43
  • [4] Health-economic comparison of continuous subcutaneous insulin infusion with multiple daily injection for the treatment of Type 1 diabetes in the UK: Response to Roze et al.
    DeVries, JH
    DIABETIC MEDICINE, 2006, 23 (06) : 709 - 709
  • [5] About the article: "Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis" by Jacobs LD et al.
    Labetoulle, M
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2001, 24 (02): : 222 - 222
  • [6] Invited commentary on Ahmad et al.: Routine botulinum toxin injection one month after a Swenson pull-through does not change the incidence of Hirschsprung associated enterocolitis
    Gosain, Ankush
    Goldstein, Allan M.
    JOURNAL OF PEDIATRIC SURGERY, 2022, 57 (08) : 1458 - 1459
  • [7] Comment on: Comparative characteristics of older people with type 1 diabetes treated with continuous subcutaneous insulin infusion or insulin injection therapy: data from the German/Austrian DPV registry. Reply to Rigalleau et al.
    Grammes, J.
    Kuestner, E.
    Dapp, A.
    Hummel, M.
    Kaemmer, J. -C.
    Kubiak, T.
    Schuetz-Fuhrmann, I.
    Zimny, S.
    Bollow, E.
    Holl, R. W.
    DIABETIC MEDICINE, 2020, 37 (07) : 1209 - 1210
  • [8] Commentary on the article: "Maintenance of wellness in patients with obsessive-compulsive disorder who discontinue medication after exposure/response prevention augmentation A randomized clinical trial" Foa EB et al., JAMA Psychiatry. 2022;79(3):193-200 (1)
    Fineberg, Naomi A.
    Hollander, Eric
    Grant, Jon E.
    Chamberlain, Samuel R.
    Drummond, Lynne M.
    Pellegrini, Luca
    Laws, Keith R.
    Wellsted, David
    Reid, Jemma
    Nezgovorova, Vera
    Baldwin, David S.
    COMPREHENSIVE PSYCHIATRY, 2022, 116
  • [9] Commentary on "Rupestonic acid derivative YZH-106 suppresses influenza virus replication by activation of heme oxygenase-1-mediated interferon response" by Ma et al. [Free Radic. Biol. Med. 96 (2016) 347-361]
    Crawford, Dana R.
    FREE RADICAL BIOLOGY AND MEDICINE, 2016, 96 : 465 - 466
  • [10] Revision Surgery After TJR: A Family Affair? Commentary on an article by Anders Bruggemann, MD, PhD, et al.: "Risk of Revision After Arthroplasty Associated with Specific Gene Loci. A Genomewide Association Study of Single-Nucleotide Polymorphisms in 1,130 Twins Treated with Arthroplasty"
    van Wijnen, Andre J.
    Lewallen, Eric A.
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2022, 104 (07):
12